Does eczema have your skin feeling itchy and looking red and scaly no matter what you try, making you wonder if there will ...

Orismilast may be an effective and safe novel treatment option for adult patients with moderate to severe atopic dermatitis.

Arcutis Biotherapeutics (ARQT) announced that Pediatric Dermatology published online positive results from INTEGUMENT-PED, the pivotal phase 3 ...

The FDA has cleared an Investigational New Drug Application for Zabalafin Hydrogel, a multi-target therapy for mild to ...

Clinical Care Options in collaboration with the National Eczema Association is hosting an innovative and engaging symposium IL-13 Inhibition in Moderate to Severe Atopic Dermatitis: A Clinical Skills ...

Jason B. Pieper, DVM, MS, DACVD: The causes for otitis externa. I mean, definitely the number one is going to be allergies, which then usually are going to be food allergies and atopic dermatitis or ...

Photys Therapeutics Inc. has signed a license agreement with Hangzhou Polymed Biopharmaceuticals Inc. for HPB-143, a phase I-ready IRAK-4 degrader. IRAK-4 degradation offers potential to treat various ...

The clinical and financial implications of inpatient dermatology were examined, highlighting the need for systemic changes to ...

Many skin conditions appear differently in melanated skin, leading to misdiagnosis and poor treatment. Understanding these ...

Evelo Biosciences, Inc. (NASDAQ:EVLO – Get Free Report) was the recipient of unusually large options trading on Wednesday. Stock traders purchased 1,885 put options on the company. This is an increase ...

Signal transducer and activator of transcription 6 (STAT6) is a member of the STAT family involved in the regulation of immune response and inflammation. The development of SH2 domain inhibitors ...